Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Samil Pharmaceutical Co., Ltd. Appoints New Co-CEO


Friday, 22 Mar 2013 01:06am EDT 

Samil Pharmaceutical Co., Ltd. announced that it has appointed Huh Seung Beom as its new Co-Chief Executive Officer (Co-CEO), effective March 22, 2013. The current Chief Executive Officer, Huh Gang, continues his duty as Co-CEO at the Company. 

Latest Developments for Samil Pharmaceutical Co Ltd

Company Quote

5810.0
60.0 +1.04%
1:00am EST